http://www.fool.com.au/2015/05/29/alchemia-limited-slammed-53-is-the-stock-a-buy/
Alchemia Limited (ASX:ACL), today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug...
Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received U.S. regulatory approval to launch a copy of GlaxoSmithKline PLC's (GSK...
Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has...
Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received final approval from the U.S. Food and Drug Administration to sell a...
Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update...
Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection...
Alchemia’s (ASX: ACL) subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research...
Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an...
("Alcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd Time," published at 6:12 p.m. EDT, incorrectly included a tax benefit for the latest...
Alcon Inc.'s (ACL) third-quarter profit dropped 18% as foreign-exchange rates took a toll, but the eye-care products giant again raised its 2009...
-- Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration -- Deal provides path for Alcon to...
Presentation to be Webcast on September 29, 2009 EMERYVILLE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE-AMEX:...
Nestle S.A. (NESN.VX) doesn't sees any acquisition opportunities at present, an official said Wednesday. "There's nothing available at the right...
Nestle SA (NESN.VX) said Monday it sees no reason to renegotiate deal terms on eyecare company Alcon Inc. (ACL) with Swiss drugmaker Novartis AG...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.